Exploring Triaging and Short-Term Outcomes of Early Invasive Strategy in Non-ST Segment Elevation Acute Coronary Syndrome: A Report from Japanese Multicenter Registry

This observational study aimed to examine the extent of early invasive strategy (EIS) utilization in patients with non-ST elevation acute coronary syndrome (NSTE-ACS) according to the National Cardiovascular Data Registry (NCDR) CathPCI risk score, and its association with clinical outcomes. Using a...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2020-04, Vol.9 (4), p.1106
Main Authors: Ikemura, Nobuhiro, Shiraishi, Yasuyuki, Sawano, Mitsuaki, Ueda, Ikuko, Numasawa, Yohei, Noma, Shigetaka, Suzuki, Masahiro, Momiyama, Yukihiko, Hayashida, Kentaro, Yuasa, Shinsuke, Miyata, Hiroaki, Fukuda, Keiichi, Kohsaka, Shun
Format: Article
Language:English
Subjects:
Acute coronary syndromes
Angina pectoris
Cardiovascular disease
Clinical medicine
Creatinine
Electrocardiography
Heart failure
Hemodialysis
Kidneys
Length of stay
Mortality
Patients
Quality of care
Stroke
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This observational study aimed to examine the extent of early invasive strategy (EIS) utilization in patients with non-ST elevation acute coronary syndrome (NSTE-ACS) according to the National Cardiovascular Data Registry (NCDR) CathPCI risk score, and its association with clinical outcomes. Using a prospective multicenter Japanese registry, 2968 patients with NSTE-ACS undergoing percutaneous coronary intervention within 72 hours of hospital arrival were analyzed. Multivariable logistic regression analyses were performed to determine predictors of EIS utilization. Additionally, adverse outcomes were compared between patients treated with and without EIS. Overall, 82.1% of the cohort ( = 2436) were treated with EIS, and the median NCDR CathPCI risk score was 22 (interquartile range: 14-32) with an expected 0.3-0.6% in-hospital mortality. Advanced age, peripheral artery disease, chronic kidney disease or patients without elevation of cardiac biomarkers were less likely to be treated with EIS. EIS utilization was not associated with a risk of in-hospital mortality; yet, it was associated with an increased risk of acute kidney injury (AKI) (adjusted odds ratio: 1.42; 95% confidence interval: 1.02-2.01) regardless of patients' in-hospital mortality risk. Broader use of EIS utilization comes at the cost of increased AKI development risk; thus, the pre-procedural risk-benefit profile of EIS should be reassessed appropriately in patients with lower mortality risk.
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm9041106